MIT v. Shire Pharmaceuticals, Inc., No. 15-1881 (Fed. Cir. Oct. 13, 2016)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Massachusetts Institute of Technology and Children’s Medical Center Corporation (collectively, “MIT”) brought suit agains t Shire Pharmaceuticals, Inc. and Shire R e- generative Medicine, Inc. (collectively, “Shire”) for i n- fringement of U.S. Patent Nos. 5,770,193 and 5,759,830. The ’193 and ’830 patents are directed to three - dimensional scaffolding for growing cells in vitro to pro- duce organ tissue in vivo.